Luye Pharma Group Stock Analysis

Luye Pink Sheet Analysis Notes

About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Luye Pharma was now reported as 2.54. The company last dividend was issued on the 29th of June 2020. Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide. The company was founded in 1994 and is headquartered in Yantai, the Peoples Republic of China. Luye Pharma is traded on OTC Exchange in the United States.The quote for Luye Pharma Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Luye Pharma Group learn more at https://www.luye.cn.

Luye Pharma Group Investment Alerts

Luye Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Luye Pharma's market, we take the total number of its shares issued and multiply it by Luye Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Luye Profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Technical Drivers

As of the 8th of January, Luye Pharma secures the Risk Adjusted Performance of 0.1028, mean deviation of 0.2888, and Standard Deviation of 1.19. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Luye Pharma Group, as well as the relationship between them. Please verify Luye Pharma Group risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Luye Pharma Group is priced some-what accurately, providing market reflects its recent price of 0.34 per share. As Luye Pharma Group appears to be a penny stock we also strongly suggest to check its information ratio numbers.

Luye Pharma Group Price Movement Analysis

Luye Pharma Predictive Daily Indicators

Luye Pharma Forecast Models

Luye Pharma's time-series forecasting models are one of many Luye Pharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Luye Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Luye Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Luye shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Luye Pharma. By using and applying Luye Pink Sheet analysis, traders can create a robust methodology for identifying Luye entry and exit points for their positions.

When running Luye Pharma's price analysis, check to measure Luye Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Luye Pharma is operating at the current time. Most of Luye Pharma's value examination focuses on studying past and present price action to predict the probability of Luye Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Luye Pharma's price. Additionally, you may evaluate how the addition of Luye Pharma to your portfolios can decrease your overall portfolio volatility.